These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1190711)

  • 1. [Proceeding: Production rate, metabolic clearance rate and mean plasma concentration of cortisol in hyperthyroidism (author's transl)].
    Linquette M; Lefebvre J; Racadot A; Cappoen JP
    Ann Endocrinol (Paris); 1975; 36(1):35-6. PubMed ID: 1190711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Production rate and mean plasma concentration of cortisol in hyperthyroidism (author's transl)].
    Linquette M; Lefebvre J; Racadot A; Cappoen JP; Fontaine-Delort S
    Ann Endocrinol (Paris); 1976; 37(5):331-45. PubMed ID: 1020919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adrenocorticotropin (ACTH) values and cortisol response to 250 and 1 microg ACTH stimulation in patients with hyperthyroidism before and after carbimazole therapy: case-control comparative study.
    Mishra SK; Gupta N; Goswami R
    J Clin Endocrinol Metab; 2007 May; 92(5):1693-6. PubMed ID: 17327382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement.
    Iranmanesh A; Lizarralde G; Johnson ML; Veldhuis JD
    J Clin Endocrinol Metab; 1990 Jan; 70(1):155-61. PubMed ID: 2294128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum cortisol level variations in thyroid diseases].
    Seck-Gassama ; Ndoye O; Mbodj M; Akala A; Cisse F; Niang M; Ndoye R
    Dakar Med; 2000; 45(1):30-3. PubMed ID: 14666786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thyroid function on the in vivo cortisol in equilibrium cortisone equilibrium in man.
    Zumoff B; Bradlow HL; Levin J; Fukushima DK
    J Steroid Biochem; 1983 Apr; 18(4):437-40. PubMed ID: 6834828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis.
    Kerrigan JR; Veldhuis JD; Leyo SA; Iranmanesh A; Rogol AD
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1505-10. PubMed ID: 8501158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic clearance and blood production rates of estradiol in hyperthyroidism.
    Ridgway EC; Longcope C; Maloof F
    J Clin Endocrinol Metab; 1975 Sep; 41(3):491-7. PubMed ID: 1159057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic activity of adrenal function and seasonal variations of cortisol peripheral metabolism in a hibernating mammal, the hedgehog (Erinaceus europaeus L.) (author's transl)].
    Saboureau M; Bobet JP; Boissin J
    J Physiol (Paris); 1980 Nov; 76(6):617-29. PubMed ID: 7441572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
    Lizcano F; Salvador J
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ACTH and cortisol on aldosterone and cortisol clearance and distribution in plasma and whole blood.
    Zipser RD; Speckart PF; Zia PK; Edmiston WA; Lau FY; Horton R
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1101-9. PubMed ID: 186476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic glucose production and splanchnic glucose exchange in hyperthyroidism.
    Wennlund A; Felig P; Hagenfeldt L; Wahren J
    J Clin Endocrinol Metab; 1986 Jan; 62(1):174-80. PubMed ID: 3510000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.
    Bergendahl M; Vance ML; Iranmanesh A; Thorner MO; Veldhuis JD
    J Clin Endocrinol Metab; 1996 Feb; 81(2):692-9. PubMed ID: 8636290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cortisol response to 1-24 adrenocorticotropin in patients with treated/untreated sellar & suprasellar mass lesions.
    Bhansali A; Sreenivasulu P; Subrahmanyam KA; Sharma BR; Dash RJ
    Indian J Med Res; 2004 May; 119(5):190-4. PubMed ID: 15218981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.